Angiogenesis activation is the main oncogenic pathway of MTM-HCC, with over-expressed angiogenic-2 and vascular endothelial growth factor coordinating with each other to promote angiogenesis [37]. The gene discussed is MT1DP; the disease is hepatocellular carcinoma.